Sunshine Biopharma, Inc. announced that it has received CAD 900,000 in a round of funding from existing investor RB Capital Partners, Inc. on July 20, 2021. The company has issued convertible debt in transaction. The debt is convertible into shares at a fixed price of CAD 0.30 per share. The investor has invested just over CAD 3,500,000 in the company.